Related Experiment Video
Updated: May 18, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Hemorrhagic complications associated with dabigatran use.
Betty C Chen1, Aaron D Viny, Fiona M Garlich
1New York City Poison Control Center, Bellevue Hospital Center, New York University, New York, NY 10016, USA. betty.chen@nyumc.org
Clinical Toxicology (Philadelphia, Pa.)
|September 14, 2012
Summary
The lack of a reversal agent for dabigatran (a direct thrombin inhibitor) is a concern for uncontrollable bleeding. This case series highlights bleeding risks, especially with other medications or health issues.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Dabigatran, a direct thrombin inhibitor, is used for anticoagulation in non-valvular atrial fibrillation and post-orthopedic surgery.
- While effective in reducing thromboembolism, dabigatran use carries a bleeding risk due to challenges in monitoring and lack of a reversal agent.
Observation:
- Four cases of dabigatran-related bleeding are presented, including rectal bleeding, epistaxis, cardiac tamponade, and subdural hematoma.
- Patient outcomes varied, with one fatality despite interventions, highlighting the severity of potential bleeding events.
Findings:
- The absence of a specific reversal agent for dabigatran poses a significant concern for managing uncontrollable bleeding and potential mortality.
- Contributing factors to bleeding in these cases included concomitant use of antiplatelet agents, renal insufficiency, advanced age, and fall risk.
Implications:
- Wider clinical use of dabigatran may lead to higher-than-anticipated bleeding rates.
- Clinicians should carefully consider patient risk factors, including bleeding diathesis and concomitant medications, when prescribing dabigatran.
- The development of a reversal agent for dabigatran is crucial for improving patient safety and managing emergent bleeding complications.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...